Efficacy of Low-dose Interleukin-2 Treatment in Chronic Spontaneous Urticaria

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
This study is a randomized, controlled, single-center clinical study to evaluate the short-term efficacy of low-dose Interleukin-2 injection as an add-on therapy for the treatment of patients aged 18-75 who have been diagnosed with CSU and remain symptomatic despite oral antihistamine treatment .
Epistemonikos ID: 65be4f79bc83cbd990cf4ffbc03a5d5bb38257aa
First added on: Dec 20, 2022